Buy, stick away and don't look at it for quite awhile. Costs are low on R & D because they tend to buy compounds that have already been researched. Not cheap.
Stock price has been cut in half since March/04 because of their depression drug which is coming off patent. Creating their own generic drug. Great company. Juggernaut sales force. Has about $4 of cash. Has a product ramp in alzheimers.